Review: taking Januvia and Victoza together


Summary

Drug interactions are reported among people who take Januvia and Victoza together. This review analyzes the effectiveness and drug interactions between Januvia and Victoza. It is created by eHealthMe based on reports of 728 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Januvia

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. (latest outcomes from Januvia 37,219 users)

Victoza

Victoza has active ingredients of liraglutide. It is often used in type 2 diabetes. (latest outcomes from Victoza 22,251 users)

On Sep, 16, 2016

728 people who take Januvia, Victoza are studied.


Number of reports submitted per year:

Januvia and Victoza drug interactions.

Drug effectiveness over time:

Januvia:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Victoza:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Januvia:
  • female: 0.0% - (0 of 1 people)
  • male: 33.0% - (1 of 3 people)
Victoza:
  • female: 0.0% - (0 of 1 people)
  • male: 33.0% - (1 of 3 people)

Drug effectiveness by age:

Januvia:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 2 people)
Victoza:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • pancreatitis
  • pancreatitis acute
  • pancreatic carcinoma
  • abdominal pain
  • pancreatic pseudocyst
  • vomiting
  • diarrhoea
  • constipation
  • death
1 - 6 months:
  • pancreatic carcinoma
  • pancreatic carcinoma metastatic
  • pancreatitis
  • metastases to liver
  • hypertension
  • constipation
  • pancreatitis acute
  • depression
  • diabetes mellitus inadequate control
  • adenocarcinoma pancreas
6 - 12 months:
  • pancreatic carcinoma
  • pancreatic carcinoma metastatic
  • pancreatitis
  • metastases to liver
  • hypertension
  • death
  • depression
  • ascites
  • constipation
  • hypercholesterolaemia
1 - 2 years:
  • pancreatic carcinoma
  • pancreatic carcinoma metastatic
  • metastases to liver
  • constipation
  • death
  • hypertension
  • drug ineffective
  • pancreatitis
  • anaemia
  • diabetes mellitus inadequate control
2 - 5 years:
  • pancreatic carcinoma
  • pancreatic carcinoma metastatic
  • pancreatitis
  • back pain
  • metastases to liver
  • constipation
  • deep vein thrombosis
  • anaemia
  • death
  • gastrooesophageal reflux disease
5 - 10 years:
  • pancreatic carcinoma
  • metastases to liver
  • cholangiocarcinoma
  • death
  • breast cancer
  • adenocarcinoma pancreas
  • depression
  • gastrooesophageal reflux disease
  • hypertension
  • itching
not specified:
  • blood glucose increased
  • nausea
  • pancreatic carcinoma
  • pancreatitis
  • drug ineffective
  • weight decreased
  • abdominal pain
  • diarrhoea
  • headache
  • pancreatitis acute

Most common drug interactions by gender *:

female:
  • pancreatic carcinoma
  • pancreatitis
  • nausea
  • metastases to liver
  • headache
  • blood glucose increased
  • diarrhoea
  • pancreatic carcinoma metastatic
  • drug ineffective
  • constipation
male:
  • pancreatic carcinoma
  • pancreatic carcinoma metastatic
  • pancreatitis
  • blood glucose increased
  • nausea
  • constipation
  • pancreatitis acute
  • abdominal pain
  • metastases to liver
  • diabetes mellitus inadequate control

Most common drug interactions by age *:

20-29:
  • decreased appetite
  • thyroid cancer
  • weight decreased
  • colon cancer stage iii
  • rectal haemorrhage
  • angioedema
  • autoimmune thyroiditis
  • blood glucose increased
  • choking
  • confusional state
30-39:
  • pancreatitis acute
  • blood glucose increased
  • glycosylated haemoglobin increased
  • myasthenia gravis
  • thymoma malignant
  • weight decreased
  • abdominal pain
  • musculoskeletal pain
  • overdose
  • pain
40-49:
  • pancreatitis
  • blood glucose increased
  • nausea
  • glycosylated haemoglobin increased
  • pancreatitis acute
  • ileus
  • vomiting
  • diarrhoea
  • flatulence
  • abdominal discomfort
50-59:
  • pancreatic carcinoma
  • pancreatitis
  • blood glucose increased
  • nausea
  • diarrhoea
  • drug ineffective
  • pancreatic pseudocyst
  • pancreatitis acute
  • vision blurred
  • cholangiocarcinoma
60+:
  • pancreatic carcinoma
  • pancreatic carcinoma metastatic
  • nausea
  • pancreatitis
  • blood glucose increased
  • headache
  • metastases to liver
  • weight decreased
  • constipation
  • pancreatitis acute

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Januvia and Victoza?

Can you answer these questions?

More questions for: Januvia, Victoza

You may be interested in these reviews

More reviews for: Januvia, Victoza

On eHealthMe, Januvia (sitagliptin phosphate) is often used to treat diabetes. Victoza (liraglutide) is often used to treat type 2 diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.